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Abstract
In the recent past years, micropollutants that are pharmaceutically active compounds
(PhACs) have been used extensively and have been discovered in raw sewage, waste-
water treatment plants, effluents, surface, and groundwater with concentrations from
ng/L to several μg/L. Even though many of these compounds are still not determined
online, monitoring technology improvements progressed. Today’s wastewater treat-
ment plants are not constructed to remove these micropollutants yet. Conventional
activated sludge processes are used in the treatment of municipal wastewater but are
not specifically designed for the removal of micropollutants. The remaining pharma-
ceuticals mix into surface waters. At that stage, they can adversely affect the aquatic
environment and may cause issues for drinking water production. As the conventional
methods are insufficient for removing the micropollutants, other alternative treatment
methods can be applied such as coagulation-flocculation, activated carbon adsorption
(powdered activated carbon and granular activated carbon), advanced oxidation pro-
cesses, membrane processes, and membrane bioreactor. It has been observed that
membrane bioreactor (MBR) can achieve higher and more consistent micropollutants
removal. The removal of micropollutants is based on physicochemical properties of
micropollutants and the conditions of treatment. Due to recent technical innovations
and cost reductions of the actual membranes, the membrane bioreactor takes attention.
In this study, membrane bioreactor experiments for micropollutants in drinking use,
wastewater, and surface waters were investigated in detail based on literature investi-
gations, and the feasibility of this method was evaluated.
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1. Introduction
Pharmaceutical wastewater is one of the most important gateways of emerging pollutants
(such as synthetic hormones including corticosteroids) to enter water bodies. During the last
years, numerous studies have documented the presence of many of these substances at the
level of microgram or nanogram per liter in raw water (i.e., stream/source water), in waste-
water effluents, and even in finished drinking waters [1, 2]. As a consequence, pharmaceuti-
cals are entering in the trophic chain and causing adverse ecological and human health
effects [3].
Pharmaceuticals are not regulated at the moment in the EU, but the 2013 amendment of the
Environmental Quality Standards Directive (2008/105/EC) contains a mechanism to collect
high-quality data on concentration of compounds of environmental concern, the so-called
watchlist. This list includes diclofenac, 17-beta-estradiol (E2), and 17-alpha-ethinylestradiol
(EE2). For compounds on this list, it is likely that regulations will be developed in the future.
This would mean that additional treatment of wastewater will be necessary to comply with
these regulations [4].
Membrane bioreactor (MBR) technique is a promising alternative to conventional treatment,
[5, 6], and its usage is increasingly for municipal wastewater treatment and reuse, and great
concerns have been raised to some emerging trace pollutants found in aquatic environment in
the last decade, notably the pharmaceuticals [7]. In that sense, recently a pilot MBR was
innovatively applied leading to removal efficiencies over 95% of the chemical oxygen demand
(COD). Furthermore, other lab-scale MBR studies have been focused not only in the removal of
the bulk organic matter but also in the elimination of the specific organic micropollutants
present in the raw wastewater [1].
In this study, we present a comprehensive review of the studies carried out in the literature
with MBR of micropollutant residues in different wastewaters, and it is expected that these
pollutants, which are highly biologically active and difficult to biodegrade, shed light on
treatment strategies to improve biodegradation.
2. Sources of pharmaceutical micropollutants in the aquatic environment
Pharmaceuticals are important and indispensable elements of modern life. They are used in
humans and animals, in agriculture and in water culture. The presence of pharmaceuticals in
the environment first attracted the attention of the scientific community and the public in the
1970s. However, until the 1990s, little has been done about the presence, behavior, and effects
of pharmaceuticals in the environment. During this time, environmental pollutants such as
heavy metals, polycyclic hydrocarbons, dioxins, furans, pesticides, and detergents have been
extensively studied. Endocrine system drugs and lipid-lowering drugs have been on the rise
since the 1990s. After this date, many studies have been done in the USA and Europe for
hormones and other pharmaceuticals [8–10].
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An important reason why so much care is taken with pharmaceutical products is that they
have to produce a biological effect. They are made as stable as possible so that they can be
stored for a long time and easily swallowed. The membranes are lipophilic enough to cross the
membranes, and in order to reach the sites of action—especially those taken orally—drugs
must be resistant to enzymes and must not hydrolyze at acidic pH values. They must be stable
and have high mobility in liquid phase [11–13].
Because of these properties, active pharmaceutical ingredients/conversion products can be
bioaccumulated and can cause effects in aquatic or terrestrial ecosystems.
The intake of drug active substances occurs in various ways. Starting from humans and
animals, the active pharmaceutical ingredients reach the wastewater, soil, and groundwater
and, if adequate treatment is not done, reach our drinking water. Pharmaceutical products can
be roughly divided into two: medicinal products and veterinary drugs used by humans.
Veterinary medicines are used in farm animal breeding and poultry production. Medicinal
products used by humans reach sewage through urea and feces and from there to wastewater
treatment plant. If xenobiotics are taken as an example, there are three possible behaviors of
the substance: (i) the substance is completely mineralized to water and CO2 (e.g., aspirin). (ii)
The substance is lipophilic and does not easily fragment. So, some of the material is kept in
clay. (iii) The substance is metabolized to a more hydrophobic than lipophilic form but
becomes resistant. It cannot be removed in the treatment plant, and it is thrown away with
wastewater and mixed with the receiving waters. If the metabolites are still biologically active,
they also affect the aquatic organisms in the environment. Possible materials in clay, if the mud
is laid on the field, may affect microorganisms and the useful ones. Medicinal substances used
to support growth of animals in the stables are mostly fertile. These substances can affect soil
organisms. The hydrophilic materials in the sewage sludge, which are scattered in the mouth,
reach the aquatic environment by infiltrating with rain [11–13].
Pharmaceutical substances used for animals in the field are thrown directly to the ground via
urea and feces. High local concentration affects soil organisms. It is also possible that medicinal
substances spread over the surface are mineralized to the ground or reach the groundwaters.
They are used in fish farms and are directly confused with the receiving waters because the
best way to treat fish with antibiotics and other medicines is to use feed additives. Because
most of the feed additives are not eaten by the fish, they fall from the cages and accumulate in
the seabed. These substances can affect aquatic organisms. An unknown part of the medical
goods sold for human use is thrown into the toilet as waste by people and reaches the
treatment plant by interfering with the sewage system [14–17].
Micropollutants consist of a vast and expanding array of anthropogenic as well as natural
substances. These include pharmaceuticals, personal care products, steroid hormones, indus-
trial chemicals, pesticides, and many other emerging compounds. Micropollutants are com-
monly present in waters at trace concentrations, ranging from a few ng/L to several μg/L. The
“low concentration” and diversity of micropollutants not only complicate the associated detec-
tion and analysis procedures but also create challenges for water and wastewater treatment
processes [2].
Efficient Removal Approach of Micropollutants in Wastewater Using Membrane Bioreactor
http://dx.doi.org/10.5772/intechopen.75183
43
Sources of micropollutants in the environment are diverse, and many of these originate from
mass-produced materials and commodities. Table 1 summarizes the sources of the major
categories of micropollutants in the aquatic environment.
Pharmaceuticals are thoroughly used to cure the diseases in humans and as veterinary drugs.
These biologically active chemicals are treated as emerging contaminant due to their persis-
tence and potential harmful impact on the aquatic ecosystem.
These refractory emerging contaminants (RECs) (analgesics, anti-inflammatories, antiepilep-
tics, and antibiotics) fall into the class of endocrine-disrupting compounds, which continually
enters into the aquatic environment in small concentration.
They remain active even in low concentrations and deteriorate water quality and have an
adverse impact on the ecosystem and human health. The most common and persistent phar-
maceutical products in the aquatic environment are summarized below.
2.1. Antibiotics
In recent years, global consumption and the use of antibiotics increase to >30% [18]. Antibiotics
are generally treated as pseudo-persistent compound because of its continuous introduction in
environment. The existence and release of antibiotics are inclined to be of specific concern since
Category Important subclasses Major sources Nonexclusive
Pharmaceuticals aNSAIDs, lipid regulator,
anticonvulsants, antibiotics,
β-blockers, and stimulants
Domestic wastewater (from
excretion)
Hospital effluents
Runoff from bCAFOs and
aquaculture
Sources that are not exclusive
to individual categories
include
industrial wastewater (from
product manufacturing
discharges)
Landfill leachate (from
improper disposal of used,
defective, or expired items)
Personal care
products
Fragrances, disinfectants, UV
filters, and insect repellents
Domestic wastewater (from
bathing, shaving, spraying,
swimming, etc.)
Steroid
hormones
Estrogens Domestic wastewater (from
excretion)
Runoff from CAFOs and
aquaculture
Surfactants Nonionic surfactants Domestic wastewater (from
bathing, laundry, dishwashing, etc.)
Industrial
chemicals
Pesticides
Plasticizers, fire retardants
Insecticides, herbicides, and
fungicides
Industrial wastewater (from
industrial cleaning discharges)
Domestic wastewater (by leaching
out of the material)
Domestic wastewater (from
improper cleaning, runoff from
gardens, lawns, roadways, etc.)
Agricultural runoff
aNSAIDs, Nonsteroidal anti-inflammatory drugs.
bCAFOs, concentrated animal feeding operations.
Table 1. Sources of micropollutants in the aquatic environment.
Wastewater and Water Quality44
they are designed to kill and inhibit the growth of microorganism; thus, they will hinder the
activity of beneficial microbes in wastewater treatment plant (WWTP) operation and involved
in their removal. Moreover, for constant exposure to antibiotics, microbial community stay in
wastewater improves resistant mechanism more readily than the rest of another microbial
world. The presence of numerous antibiotic compounds was identified in untreated wastewa-
ter in both aqueous and solid phases. Overall, occurrence and persistence of antibiotics in
water bodies increase concern; almost 90% of antibiotics consumed by human body were
discharged via urine and feces [19].
2.2. Therapeutic hormones
Therapeutic hormones are the synthetic analog of animal or plant natural hormones, which
affect the endocrine system and have impacts on human and animal health. The most frequently
found hormones in the environment are estrogens. A synthetic estrogenic steroid is used as a
birth control agent and in estrogen substitution therapies. Thus, estrogen and its metabolite
become the abundant class of emerging pharmaceutical contaminants. The metabolite of 17b-
ethinyl estradiol and estrone (E1) is one of the most powerful EDCs creating impacts in aquatic
organisms. Their presence in the river environment causes adverse reproductive and develop-
mental effect in nontargeted organisms [20]. Several studies confirmed that the presence of
estrogen in both influent and effluent of municipal wastewater treatment plants at a concentra-
tion ranges from 5 to 188 ng/L and between 0.3 and 12.6 ng/L, respectively [19, 21].
2.3. Analgesic pharmaceuticals
Analgesic is the widely used drug for pain relaxation and to treat fever. Drugs belonging to the
class of analgesics such as naproxen acetaminophen, ibuprofen, diclofenac, and meprobamate
were treated as significant environment pollutants due to their persistence in the aquatic environ-
ment [22]. Almost, 15% of ibuprofen was excreted after administration and 26% as its metabolite.
The metabolite of ibuprofen is more toxic to aquatic organisms than parental compound [23]. The
presence of ibuprofen, diclofenac, naproxen, gemfibrozil, and hydrochlorothiazide in the river
shows a concentration range from 2 to 18 ng/L. The occurrence of these xenobiotic compounds in
natural water bodies represents a significant concern for human health as little information is
available on the effect of long-term ingestion of these compounds through drinking water [19].
2.4. By-product and metabolites
Pharmaceutical compounds pass on a set of biochemical transformation in human and animal
body and form polar, hydrophilic, and biologically active metabolites, which are discharged
through urine and feces and enter WWTP. These active metabolites are accumulated in tissues
of aquatic organisms. They have the potential to bind covalently to their cellular protein andmay
evoke an immune response or exert toxic effects [25]. These metabolites are reported to be 50%
more toxic than their parental compounds. The poorly metabolized parental pharmaceutical
substances undergo a transformation and affect the action of microbial community present in
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the WWTP. These metabolites are persistent due to their weaker sorption potential and high
mobility and, thus, detected in environmental samples [26].
Literature reported that the concentration of the metabolite in influent and effluent of WWTP
is often higher than their parental compounds, and their fate depends on the environmental
conditions such as salinity, temperature, pH, and microbial diversity [19, 27].
Many studies on removal of pharmaceutical compounds from wastewater have been conducted,
and many treatment technologies of hospital wastewater treatment have been developed.
Treatment of pharmaceutical residues using MBR processes was discussed in the following
sections.
3. General features of MBR systems
Membranes have been used for many years as biological treatment (aerobic and anaerobic)
and solid–liquid separation methods in physical applications. Nowadays, these methods are
increasingly attracted to the name of membrane bioreactors combined with biological waste-
water treatment [28]. Membrane bioreactor technology is emerging as a mature technology
around the world with many full-scale installations for municipal and different wastewater
treatments [29–31]. The reactor is operated in a similar manner to a conventional activated
sludge process, and there is no need for tertiary stages such as secondary purification and sand
filtration. Low-pressure membrane filters such as microfiltration (MF) or ultrafiltration (UF)
are used to separate wastewater from the activated sludge [32].
Several factors have been reported that may affect contamination in MBR membrane properties
such as floc size, mixed liquid viscosity, mixed liquid viscosity, pH, solubility, associated poly-
meric compounds (EPS), pore size, porosity, surface charge, roughness, and hydrophilicity/hydro-
phobicity. Operating parameters such as hydraulic retention time (HRT), solid retention time
(SRT), and food/mass (F/M) ratio do not have a direct effect on membrane contamination [33,
34]. They affect more sludge properties and therefore sludge filtration properties. Organic con-
tamination is caused by contamination of the membrane during active sludge filtration compared
to inorganic pollution [35].
3.1. MBR configuration
There are two membrane-type alternatives: the first option is submerged MBR configuration
such as operating under a vacuum, instead of direct pressure. This configuration may be named
immersed as the membrane is placed directly into the liquid. The second option is sidestream
MBR configuration such as operating under pressure. In this approach, the membrane is sepa-
rated from the bioreactor, and a pump is required for pushing the bioreactor effluent into the
membrane system and permeates through the membrane. This configuration may be named
external cross flow membrane. Flat sheet (FS) and hollow fiber (HF) membranes are generally
used for submerged MBR configuration [36]. The two main MBR configurations involve either
submerged membranes or external circulation (sidestream configuration) (Figure 1) [32].
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Since submerged MBRs operate at lower operating fluxes, they have greater hydraulic
efficiency due to greater permeability. Working with low flux is important in submerged
MBR because this application minimizes membrane contamination or plugging. Membrane
blockage is one of the major disadvantages of MBRs and requires cleaning mechanisms that
increase cost and make operation difficult. While submerged MBRs require lower pumping
costs than external MBRs, they require more aeration. The reason is that the aeration is the
main method to prevent membrane clogging. In addition, low flux studies in submerged
MBRs require more membrane surface area (and hence greater initial investment cost) when
based on constant permeate flux production. Despite these disadvantages, however, the
selected and implemented configuration for medium- and large-scale municipal wastewater
treatment is the internal submerged MBR [38].
By the year 1990s, this existing accumulation has been rapidly increased by the MBR applica-
tions which are made as academic and field studies. MBR producers are Kubota from Japan,
Zenon from Canada, Mitsubishi Rayon, and US Filtration [36, 39, 40] (Table 2).
Figure 1. Configuration of MBR systems: (a) submerged (immersed) MBR and (b) sidestream (external) MBR configura-
tion (adapted from [32, 37]).
Items Zenon Mitsubishi
Rayon
Tianjin
Motimo
Kubotab Shanghai
Zizheng
(1) Membrane module properties
Polymer PVDF PE PVDF PE PVDF
Filtration type UF MF MF MF MF
Module Hollow fiber Hollow fiber Hollow fiber Flat sheet Flat sheet
Hydrophilic Yes Yes Yes Yes Yes
Outside diameter (mm) 1.95 — 1.00 490 (width) 460 (width)
Inside diameter (mm) 0.92 — 0.65 1000 (height) 1010 (height)
Fiber length (mm) 1650 663.5 1010 6 (thickness) 7 (thickness)
Pore size (μm) 0.04 0.4 0.2 0.4 0.2
Surface area (m2) 23/module 105/module 20/module 0.8/panel 0.7/panel
Normal flux (L/(m2h) 25.5 10.3–16.7 15 25.5 20–30
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3.2. Design and operating parameters
A number of parameters must be considered in order to activate an economically appropriate
MBR system. These include membrane selection, membrane performance (permeate flow,
transmembrane pressure, viscosity), biological performance of microorganisms (biomass con-
centration, ESS, HBS, F/M ratio), and economic factors (energy consumption, sludge treatment,
and disposal cost). These parameters can influence each other, and a positive change can be
observed in the other parameter by changing one parameter. For example, a high biomass
concentration requires a long CIS, which in turn reduces the cost of sludge disposal and sludge
disposal. On the other hand, at high sludge age, the cost of energy also increases as the sludge
reaches a viscous structure, which leads to the decomposition of the organic fraction and the
amount of oxygen needed to grow the microorganism [43–45].
These designed and operational parameters are used to design the reactor and to be able to
differentiate in different configurations applied to the process, to give formulas which are used
in the general working principles of MBRs, also in the definition and calculation.
The amount of liquid drained from the surface area of the membrane is called flux. MBRs are
mostly 10–100 LMH flux values.
Items Zenon Mitsubishi
Rayon
Tianjin
Motimo
Kubotab Shanghai
Zizheng
(2) MBR performance
aMLSS (g/L) 12–30 <15 15–30 10–30
Aeration per module (m3/h) 14 57–73 — 0.6/panel
SRT (d) 10–100 <60 >40 40
Sludge yield (kg MLSS/kg BOD) 0.1–0.3 — 0.26
BOD effluent (mg/L) <2 2–6 — 3–5
NH3 effluent (mg/L) <0.3 — <2 <2
Cleaning method Back pulse and relax Relax — Relax
Cleaning frequency (min/min) 0.5/15 2/12 1/60
Recovery method Chemical soak Chlorine
backwash
Chlorine
backwash
Recovery frequency ≥3 months ≥3 months ≥6 months
Recovery location Drained cell or in situ In situ In situ
aMLSS, Mixed liquor suspended solids.
bAlthough Kubota was not found very active in China, it was still referenced here in order to compare flat-sheet
membranes made in China and those made in other countries.
Table 2. Summary comparison of membranes used in full-scale MBRs and MBR performance (adapted from [39, 41, 42]).
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3.3. Advantage and disadvantage of MBR
The best feature of MBRs is that they can easily convert existing activated sludge systems into
MBR systems. This can be accomplished by placing submerged membranes in the aeration tank
[46]. Membrane bioreactor is separating biological treatment of microorganisms and secondary
cleaners from one site to another. The feed water is mixed with the biomass, the mixture is
filtered from the membrane, and the biomass is separated from the treated water. Conventional
activated sludge (CAS) units compared to the same operational conditions to provide better
recovery efficiency in the MBR. Using MBR has many advantages [22, 47] (Table 3).
At higher MLSS concentrations, the ability to work at higher SRT than conventional treatments,
reduced biomass yield, higher quality waste, less hydraulic residence time and lower area
footprint generation are advantages of MBRs compared to CAS units [48]. This means a small
reactor volume and a reduction in the initial investment cost. They are also more resistant to
sudden different hydraulic and organic loads and better respond to existing sustainability criteria
for municipal wastewater systems [49]. Biomass separation is independent of the ability of the
activated sludge to precipitate as it is achieved bymicrofiltration or ultrafiltration; in other words,
there is no need for final sedimentation, no sludge swelling, and sedimentation problems caused
by filament growth. Due to high MLSS concentrations, excess organic loading can be done in the
system. MBRs are less likely to be negatively affected by nitrification or by business problems
related to the toxic effects of toxic organisms [50]. Since the sludge from the membrane system is
less than the conventional system, the storage requirement is also reduced [51].
MBRs are becoming increasingly common throughout the world, despite the fact that they
can reduce their investment and operating costs and produce effluent that cannot be used
despite their different reuse areas. One of the biggest causes of this is the clogging of the
wastes, and the transmembrane pressure (TMP) increases to provide a constant flux. Occlu-
sions may occur at the membrane surface or within the membrane pores. Membrane clogs
MBR CAS
Meets sensitive discharge standards Cannot meet sensitive discharge standards
Decreased reactor volume and foot print Large area is required for the secondary clarifier
Used as a pretreatment for reverse osmosis (RO) and nanofiltration
(NF) with good effluent quality
Less quality effluent is obtained
Complete retention of bacterial flocs by the membrane Needs disinfection step
Biomass retention is achieved by the membrane Biomass retention is accomplished by gravity
Operated at elevated solid retention time (SRT) Usually operates with low SRT
Better removal efficiency for slowly biodegradable micropollutants The low SRT in ASP cannot allow this
High MLSS (10–15 g L1) and low feed to microorganism ratio (F/M) MLSS is about four times less than that of MBR
Long SRT and high MLSS imply low sludge yield Low SRT and low MLSS imply high sludge yield
Table 3. Comparison of MBR and CAS (adapted from [52]).
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are roughly divided mechanically into two: recycled (removal of the surface gel and cake layer
by aeration or physical backwash) and irreversible (removal of dissolved or colloidal substances
in the adsorptive pore accumulation and clogging by chemical cleaning) [53]. MLSS, particle size
distribution, soluble microbial by-products, extracellular polymeric materials, viscosity, pore
size, porosity, surface energy, electrical charge, hydrophilic/hydrophobic properties parameters
are affecting clogging [54]. The formation of cake, which is unavoidable on the membrane
surface, is one of the factors that cause the membrane to become contaminated. In a general
system, the sidestream of theMBR shows a higher tendency to pollute than the submergedMBR.
The reason is that the sidestreamMBR needs high pump energy to generate high flux which will
cause repetition of pollution when compared to the submerged MBR [37]. Tank reduces produc-
tion, increases operating and maintenance costs, and requires a special extra cleaning and
backwashing. Membrane replacement is challenging. There are more than 10 years of MBR
systems. On the other hand, there are many systems that change after 4 years. The main causes
are often pollution problems. When contamination is combined with high transmembrane
pressure, this contamination is most irreversible, and therefore the chemical cleaning frequency
should be increased. This leads to an increase in operating cost by reducing membrane life [51].
The main contributors to energy costs in MBR are sludge transfer, permeate production, and
aeration which is often exceeding 50% of total energy consumption. Energy consumption of
membrane-relatedmodules was in the range of 0.5–0.7 kWh/m3, and specific energy consumption
for membrane aeration in flat sheet was 33–37% which was higher than in a hollow fiber system.
Submerged membranes in MBR reduces the pumping energy requirement to 0.007 kWh/m3 of
permeate compared with sidestream membrane (3.0 kWh/m3). Future trend of MBR might be
focused on two aspects which are reduction of energy demand and membrane fouling [55].
4. Micropollutant treatment studies with MBR applications
Many analgesics such as ibuprofen, diclofenac, naproxen, and ketoprofen; lipid regulators
such as bezafibrate and gemfibrozil; and carbamazepine for antiepileptic drugs were fre-
quently found to be removed at concentrations above 1.0 mg/L in domestic wastewater and
in MBR procedures [22].
While the removal rates of microcontaminants in MBR vary from one compound to another,
these removal rates, sludge retention time (SRT), biomass concentration, temperature, pH
value, class of microcontaminants and hydrophobicity, chemical structure, pKa etc. as well as
their physico-chemical properties. The hydrophobic components are removed from the liquid
phase by adsorption and, possibly, when the SRT is sufficiently high, to be removed between
the biodegradation processes [56–58]. The compactness of the MBR system, the high organic
load that can be applied, and the high SRT give good results in removing micropollutant [48].
When the pH value of the wastewater changes, it may affect the removal of micropollutants in
the negative direction. On the other hand, the role of pH on sorption has been related with the
dissociation of certain micropollutants (through the acid dissociation constant pKa), which can
result in the generation of positively charged compounds (prone to interact with the negatively
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charged surface of sludges) or anions (low interaction). Thus, the cationic species would be
adsorbed by van der Waals-type interactions [59].
Wastewater temperature also plays an important role. WWTP with an average temperature of
15–20C can be better suited for micropollutants such as in cold countries, which are often
below 10C in the USA. Summer and winter affect seasonal temperature changes, micro-
degradation, and biodegradation [60]. Sorption has been correlated inversely with tempera-
ture in the case of the hormone 17α-ethinyl estradiol (EE2), with a reduction of Kd values of
20–25% when the temperature was increased from 10 to 30C [59].
Studies have shown that compounds such as ibuprofen and antiseptic powder, methyl paraben,
and galaxolide, an analgesic drug in hospital wastewater, do not have significant differences in
effluent efficiency with activated sludge processes and MBR. MBR system was found to be
efficient for hormones (e.g., estriol, testosterone, androstenedione) and certain pharmaceuticals
(e.g., acetaminophen, ibuprofen, and caffeine) with approximately 99% removal [61, 62]. Exper-
imental investigations show that the removal of such compounds from wastewater is 30–50%
superior to that of conventional activated sludge process. In addition, the removal efficiencies
of some compounds such as mefenamic acid, indomethacin, diclofenac, and gemfibrozil in
MBR were 40%, 40%, 65%, and 32–42% [63, 64]. However, biodegradable erythromycin, TCEP,
trimethoprim, naproxen, diclofenac, carbamazepine, and nonylphenoxyacetic acid have not
been removed [47]. This is comparable to the results of previous studies which indicated very
low elimination rates of diclofenac and carbamazepine in WWTP due to their recalcitrant
nature processes in Germany. Hydrophilic compounds such as MBRs, acetaminophen, atenolol,
iopromide, and sulfamethoxazole (calculated logP <2) (with the exception of sulfamethoxazole
(> 62%) are more efficient than hydrophobic compounds. Hydrophobic compounds (calculated
log P > 2) can largely be removed by active sludge biosorption in the MBR and in the middle,
and longer holding scoops are formed in the bioreactor, resulting in a higher removal yield
from the CAS process. However, some hydrophilic microspheres such as carbamazepine and
diclofenac tend to be highly resistant to biological degradation in the treatment of CAS and
MBR. The retention time of the hydrophilic and persistent micropollutants in the bioreactor is
the same as the retention time of hydraulic retention (HRT), as the micropollutants can freely
permeate MF and UF membranes. The duration of hydraulic retention in the MBR and the
prolongation of the retention time of the sludge are dependent on the compound biosorption of
some hydrophobics for the activated sludge, and it can be seen that the pollutants can improve
the biodegradation [2, 65].
In the comparison between the two MBR modules used in this study (plate and frame versus
hollow fiber), no difference in target compound removal was found [60, 65]. Some results can
be negative efficiency. For example, González-Pérez et al. (2017) have worked on the system
that has been operated with complex nitrification and ensured that the biodegradable organic
material due to circulation is effectively retained [66]. By reducing the concentration increase in
the diclofenac (DCF) in the aerobic bioreactor, negative removal efficiencies for DCF have been
obtained. This was not observed in the anoxic reactor.
Membrane bioreactor applications for these pollutants in different wastewaters are presented
in detail given in Table 4.
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Operation mode/membrane
configuration
Volume (L)/
temperature (C)
Substrate MLSS (g SS/L)
Organic loading rate
(kg COD/m3.d)
Removal (%) Reference
Full scale (VRM)
Pilot Scale (Clear-box)
PES membrane
Plate and frame
350 L
4 C
Syntetic
wastewater
5 g/L Full
Scale
Pilot
Scale
[67]
Diltiazem 100 0
Acetaminophen 100 >95%
Estrone 10 100%
Carbamazepine 0 0
Anoxic + aerobic
hollow fiber
(MF)
PVDF Membrane
submerged
5 L
25C (5C)
Real wastewater 7 – 11 g/L
0.1 grBOD/grMLVSS
Bezafibrate
Ketaprofen
Furosemide
Atenolol
Propranolol
Diltiazen
Roxithromyan
Clarithromyun
Naproxen
Ciprofloxacin
Levofloxacin
Tetracycline
Triclosan
Triclocarban
93
87
68
58
50
57
51
46
97
36
47
52
84
42
[63]
Anaerobic reactor+ external / hollow fiber
Hybrid aerobic MBR
176 L
20 – 22 C
Synthetic wastewater 0,6 g/L
1.7 grCOD/L.d
Sulfamed hoxazole
Trimethoprim
> 84% [68]
Anoxic+Aerobic+MBR
3,6m3 + 8,8 m3 + 3,5 m3 Flat sheet (MF)
6,3 – 7.1 gr/L TSS
75 – 77 % VSS
0.83 – 0.98 kgCOD/m2d
Ibuprofen 98.12 [66]
Naproxen 98.2
Ketoprofen 92.26
DiclofenacA 20.70
DiclofenacB -18.75
Flat Sheet MF
Hallow Fiber UF
+ PAC
MFMBR➔ 30 L
UFMBR➔ 185 L
20 – 22 C
Synthetic wastewater 3grVSS/L
400 mgCOD/L
0.4 gr COD/L
MF% UF % [69]
Trimethoprim 50 40
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Operation mode/membrane
configuration
Volume (L)/
temperature (C)
Substrate MLSS (g SS/L)
Organic loading rate
(kg COD/m3.d)
Removal (%) Reference
Sulfamed hoxazole 80 70
Erythromycin 80 90
Carbamazepine 0 0
Roxithromyan 70 > 95
Aceclofenac 30 60
Naproxen 90 90
Ibuprofen 90 > 95
Ethynilestradiol 90 > 90
Estradiol 95 > 95
Naproxen 98.2
Ketoprofen 92.26
DiclofenacA 20.70
DiclofenacB -18.75
Lab scale
hollow fiber membrane model
3.2 L PVDF submerged 1.66 gVSS/L
2.16 g+COD/Lday
Levo 98.7 [1]
Betha-V 97.8
Betha-D 99.6
Medro 93.4
Pilot-scale PES UF
submerged flat sheet
Hospital effluent 2 g/L Carbamazepine 6 [70]
Trimethoprim 96
Sulfamethoxazole 7
Atenolol 99
(4.7 m3) Microfiltration (MF) Flat Sheet
(FS) membrane Module
(3.6 m3) Hollow fiber (HF) ultrafiltration
membrane
External configuration
202 C Real wastewater FS MBR HF MBR [22]
Analgesics and anti-inflammatory drugs
Ibuprofen 99.2 99.5
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Operation mode/membrane
configuration
Volume (L)/
temperature (C)
Substrate MLSS (g SS/L)
Organic loading rate
(kg COD/m3.d)
Removal (%) Reference
Naproxen 90.7 91.6
Ketoprofen 43.9 44.0
Diclofenac 65.8 62.6
Mefenamic 40.5 35.5
Propyphenazone 64.5 60.7
Acetaminophen 99.8 99.9
Indomethacin 41.4 39.7
Anti-histamines
Ranitidine 44.2 29.5
Loratidine <10 33.5
Famotidine 64.6 47.4
Anti-epileptic drug
Carbamazepine <10 <10
Psychiatric drugs
Fluoxetine 98.0 98.0
Antibiotics
Erythromycin 43.0 25.2
Sulfamethoxazole 80.8 78.3
Ofloxacin 95.2 91.3
Trimethoprim 66.7 47.5
ß-blockers
Atenolol 76.7 69.5
Sotalol 53.1 30.4
Metoprolol 44.2 29.5
W
astewater and W
ater Quality
54
Operation mode/membrane
configuration
Volume (L)/
temperature (C)
Substrate MLSS (g SS/L)
Organic loading rate
(kg COD/m3.d)
Removal (%) Reference
Propranolol 77.6 65.5
Hypoglycaemic agents
Glibenclamide 95.6 82.2
Lipid regulator and cholesterol lowering
statin drugs
Gemfibrozil 42.2 32.5
Bezafibrate 90.3 88.2
Pravastatin 86.1 83.1
Hydrochlorothiazide <10 <10
Full-scale
hollow fiber
Raw wastewater 7.5–8.5 g/L Ibuprofen ~100 [71]
Diclofenac 43
Carbamazepine 24
Sulfamethoxazole 60
Trimethoprim 30
Estrone, ~100
Estriol ~100
BisphenolA ~100
Lab-scale
hollow fiber
submerged UF modüle
Synthetic wastewater 8.6–10 g/L Ibuprofen 96.7 [72]
Diclofenac 17.3
Paracetamol 95.1
Carbamazepine 13.4
Linuron 21.1
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Operation mode/membrane
configuration
Volume (L)/
temperature (C)
Substrate MLSS (g SS/L)
Organic loading rate
(kg COD/m3.d)
Removal (%) Reference
Sulfamethoxazole 91.9
Ketoprofen 70.5
17β-estradiol 99.4
17α- ethynilestradiol 93.5
Triclocarban >98.4
Naproxen 40.1
Bisphenol A 90.4
Sulfamethoxazole 91.9
Nonylphenol 99.3
Atrazine 4.4
Flate and frame- type
hollow fiber
1 m3/d Domestic wastewater Hormones Good [60]
Acetaminophen 99
Ibuprofen 99
Caffeine 99
Others low
A pilot-scale MBR
flat-sheet membranes
submerged
21 L Municipal, hospital,
and industrial
wastewater
Aceclofenac
Carbamazepine
Diclofenac
Enalapril
Trimethoprim
 50
 0
80
> 95
> 95
[49]
Flat- sheet
(MF) membrane
submerged MBR
21L
(20  2 C)
Real wastewater
(municipal, hospital
and industrial)
Analgesics and anti-inflammatory drugs [22]
Naproxen 99.3
Ketoprofen 91.9
Ibuprofen 99.8
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Operation mode/membrane
configuration
Volume (L)/
temperature (C)
Substrate MLSS (g SS/L)
Organic loading rate
(kg COD/m3.d)
Removal (%) Reference
Diclofenac 87.4
Indomethacin 46.6
Acetaminophen 99.6
Mefenamic acid 74.8
Propyphenazone 64.6
Anti-ulcer agents
Ranitidine 95.0
Psychiatric drugs
Paroxetine 89.7
Antiepileptic drugs
Carbamazepine -
Antibiotics
Ofloxacin 94.0
Sulfamethoxazole 60.5
Erythromycin 67.3
B-blockers
Atenolol 65.5
Metoprolol 58.7
Diuretics
Hydrochlorothiazide 66.3
Hypoglycaemic agents
Glibenclamide 47.3
Lipid regulator and cholesterol lowering
statin drugs
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Operation mode/membrane
configuration
Volume (L)/
temperature (C)
Substrate MLSS (g SS/L)
Organic loading rate
(kg COD/m3.d)
Removal (%) Reference
Gemfibrozil 89.6
Bezafibrate 95.8
Clofibric acid 71.8
Pravastatin 90.8
Full-scale flat sheet Hospital effluent Ibuprofen >80 [73]
Carbamazepine <20
Diclofenac <20
MBR Concept A
MBR Concept B
10 C
10 C
10 g/L
10 g/L
Concept
A
Concept
B
[74]
Paracetamol >99 >99
Ibuprofen >99 98.5
Ketoprofen 90.1 81.3
Naproxen >97 90.2
Caffeine 99.7 99.5
Tetracycline >95 >95
Atenolol 70.8 69.1
Bisoprolol 41.9 21.7
Metoprolol 18.8 20.1
Sotalol -27.7 -33.0
Furosemide 16.3 5.6
Hydrochlorothiazide 27.5 2.4
Pilot-scale MBR
hollow fiber
PVDF
1.3 m3 Hospital
wastewater
less than 13 g/L Diclofenac
Sulfamethoxazole
Trimethoprim
0
0
0
[75]
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Operation mode/membrane
configuration
Volume (L)/
temperature (C)
Substrate MLSS (g SS/L)
Organic loading rate
(kg COD/m3.d)
Removal (%) Reference
Carbamazepine
Tramadol
Naproxen
Propanolol
Ibuprofen
17b-Estradiol
Triclosan
Gemfibrozil
0
0
23.6
34.2
100
100
100
0
Laboratory-scale MBR Feed tank (50 L)
MBR (15 L)
2.15 gCOD/L/d Amelotin (AMTN) 20-40 [76]
Pilot-scale Anoxic+Aerobic MBR Anoxic (13.8 L)
Aerobic (11.7 L)
hollow fiber
Ultrafiltration
membrane
(18  3 C)
Anoxic (4.1  0.5 and
2.7  0.3 g/L)
Aerobic (2.4  0.8 g/L
(MLSS))
Atenolol
Sulfamethoxazole
Caffeine
Naproxen
Ibuprofen
Paracetamol
Trimethoprim
Primidone
Diclofenac
Gemfibrozil
Carbamapazine
DEET
Diuron
Polyparaben
Amtriptyline
Estrone
Androsterone
Etiocholanolone
Triclosan
Triclocarban
Pilot
> 80
 60
 90
> 80
> 90
> 90
 60
 20
 20
 90
0
 80
 30
> 90
0
> 90
> 90
> 90
 60
> 90
Full Scale
> 80
> 80
> 90
> 90
> 90
> 90
 70
0
 60
> 90
0
> 90
> 90
> 90
 30
> 90
> 90
> 90
 60
 50
[77]
Table 4. Membrane bioreactor applications for micropollutants in various wastewaters.
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5. Integration of MBRs with other technologies
Membrane bioreactors (MBRs) have recently emerged with integrated MBR systems, along with
other treatment technologies. The purposes of the integrated MBR are to improve qualities of
permeates, mitigatemembrane fouling, and enhance the stability of the treatment process. Recent
studies have provided improvements in the degradation of micropollutants using integrated
Integrated technology of
MBR
Advantages Disadvantages and limitations
Advanced oxidation
processes/electrocoagulation-
MBR
Effective in removal of recalcitrant
contaminants (pharmaceutical
wastewater)
Effective in removing colors
Reduces the production of excess sludge
Easy to operate
Reduce membrane fouling
High capital and operational cost
Not effective in treatment of wastewater with
high TSS
FO-MBR Produce good effluent quality
Phosphorus recovery
Low energy consumption as compared
to conventional
MBR
Low fouling tendency compared to RO
Effective in removal of trace organic
contaminants
Fouling is largely reversible
Effective in treatment of wastewater
with high TSS as compared to RO
Uncertainly of stability of membrane
Increasing salinity/salt accumulation might
decrease the microbial kinetics and water flux
RO-MBR Low fouling tendency
Cost of RO membrane is cheaper than
FO membrane
Low energy consumption as compared
to conventional
MBR
Not effective in treatment of high-salinity
wastewater compared to FO
Membrane distillation Enhances biodegradation of recalcitrant
compounds
Low sludge yield
Higher effluent quality
Excellent process stability
Cost-effective compared to RO process
Smaller footprint
Low removal of COD
Biofilm/bio-entrapped MBR Reduces the concentration of suspended
solids
Reduce membrane fouling
Improve nitrification and denitrification
processes
Membrane fouling might be severe at the later
stage of treatment
Granular MBR Improve nitrification and denitrification
processes
High shock resistance capacity
Reduce membrane fouling
Smaller footprint
Membrane fouling might be severe at the later
stage of treatment
Long start-up period of granule formation
Table 5. Advantages and disadvantages of various integrated MBRs in wastewater treatment technology [55].
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processes. There are several methods to reduce the membrane fouling of MBR such as optimiza-
tion of HRT and SRT which were discussed in some review papers. These processes containing
biofilm carriers, suspended/attached growth system, or cross-linked enzyme aggregates showed
better removal of micropollutants, even on recalcitrant compounds such as CBZ [78].
The advantages and disadvantages of various integrated systems, such as advanced oxidation
processes (AOPs) [79], reverse osmosis (RO-MBRs) [64], forward osmosis (FO-MBRs) [80],
membrane distillation (MDBRs) [81], microbial fuel cells (MBR-MFCs) [7], anaerobic
(AnMBRs) [82], biofilm (BF-MBR) [83], and granular (GMBR) membrane bioreactors [84] to
demonstrate their ability to reduce membrane contamination, are given in the Table 5. Com-
bined MBR process configurations and conventional biological therapies, as an alternative,
resulted in more consistent results. As shown in the studies, the removal efficiency of each of
the micropollutants is different for the different membrane technologies. The value ranges
from close to zero to almost complete removal. For example, the removal efficiency of carba-
mazepine is less than 20% with ASP and MBR and up to 93% with MBR-NF and higher than
99% with MBR-RO, MBR-PAC, and MBR-GAC [52]. The use of combinations of different
complementary technologies has produced promising results. Nonetheless, there is a lack of a
holistic understanding of the nature of pollutants, their interactions, and some predictable
relationships between the best available specific technologies. More practice is needed to
evaluate the hybrid MBR systems proposed in the treatment of micropollutants [48].
6. Conclusions
In recent years, pharmaceutical products have been a cause for concern due to the persistence
of their presence in aquatic environments. Drugs are known to be involved in a variety of
aquatic environments, including domestic wastewater, hospital discharges, sewage treatment
plants, and water treatment plants.
Pharmaceutical products can preserve their original concentrations and structures, or they can
be mobilized for life in water matrices and converted to other active (or inactive) compounds.
The presence of micropollutants in aqueous environments is an increasing concern due to their
potentially harmful effects on aquatic life. Since this situation poses a serious danger to the
environment, the treatment of these pollutants is very important.
As it is clear from this work, today’s CAS is not sufficient for the destruction of many
pharmaceutical substances in the wastewater of the AAT. For these pollutants, the use of
MBR systems developed by adding membranes to CAS systems has begun to be used, and
these are often more effective at removing pollutant concentrations than traditional biological
treatment systems. MBR technology has become a reliable and valuable option with many
advantages. However, in addition to its advantages, membrane fouling is a major obstacle to
the development of these systems. To this end, it will be useful to focus on the reduction of
energy demand and membrane contamination during operation, along with the development
of integrated MBR systems, with future research. Further work is needed to assess which
system actually makes more cost–benefit and to investigate the toxicity of micropollutants
and the effect of working conditions after processing.
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